Antiseptics and Disinfectants Market Size to Worth USD 27.99 Billion by 2026

The global antiseptics and disinfectants market size is expected to reach USD 27.99 billion by 2026. It is anticipated to expand at a CAGR of 6.7 percent. Increasing prevalence of Hospital-acquired Infections (HAIs), awareness about home cleanliness and the need for disinfection, and usage of endoscope reprocesses and surgical units across the globe are the key driving factors. Rising use of Gastrointestinal (GI) endoscopes and surgical units due to the increasing rate of surgeries across the globe is expected to drive the antiseptics and disinfectants market growth. GI endoscopy is one of the important tools for the treatment and identification of disorders of the gastrointestinal tract. Proper understandings of application to GI endoscopy and infection control is very much essential as it helps to prevent transmission of infection through endoscopes and lapses in reprocessing.

Moreover, endoscopes need to be reprocessed appropriately as per the infection-control guidelines to lower the risk of acquiring environmental or patient-borne microorganisms. Thus, in such cases application of proper antiseptics and disinfectant solutions are very much essential to prevent transmission of infections. In addition, increasing rate of endoscopy is expected to surge the risk of getting such infections. For instance, as per the BMJ Publishing Group Ltd & British Society of Gastroenterology, published in 2018, the demand for gastrointestinal endoscopy has grown immensely for both and bowel cancer screening and symptomatic patients owing to which overall demand has doubled in many centers in U.K. over the last five years. Such factors are anticipated to drive the growth of antiseptics & disinfectants market.

Further key findings:

• In terms of revenue, quaternary ammonium compounds segment is expected to hold the largest market share. High prevalence of HAIs is the major factor driving the growth.
• Enzymatic cleaners are expected to witness the fastest growth. Increasing rate of surgeries is expected to drive the segment growth as the product is majorly used for disinfection of surgical kits.
• Asia-Pacific antiseptics and disinfectants market is expected to witness the fastest growth owing to the increasing number of hospitals and clinics.
• Prominent market players are BD, Johnson & Johnson, Novartis AG, and Cardinal Health. – Grand View Research